Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Third FDA panel member quits over controversial Alzheimer’s drug approval

June 11, 2021 Medical Communications

The third FDA advisory panel member has quit over the approval of a controversial new Alzheimer’s drug. Biogen’s drug, aducanumab, …
News

“The future of pain care”: Virtual reality therapy proven to aid chronic pain

June 11, 2021 Medical Communications CBT, Virtual reality, chronic pain management, technology

A novel digital therapeutics software, DTxP, has shown statistically significant benefits for patients with chronic low back pain (CLBP) in …
News

G7: UK to donate 100 million surplus vaccine doses

June 11, 2021 Medical Communications Boris Johnson, COVID-19, G7, Joe Biden, UK, US, Vaccine

Boris Johnson has announced at the G7 meeting in Cornwall that the UK will donate over 100 million surplus doses …
News
sanofi_hq__boetie_hall_web

Sutimlimab meets primary endpoint in treating cold agglutinin disease

June 11, 2021 Medical Communications

A Phase III study evaluating the safety and efficacy of sutimlimab in people with cold agglutinin disease (CAD) met its …
News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

June 11, 2021 Medical Communications

Among our ten most-read stories this week: AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions; New …
News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

June 4, 2021 Medical Communications

Among our ten most-read stories this week: NICE rejects risdiplam for treating spinal muscular atrophy; The EU wants to Fine …
News
novartis_window

Novartis’s 177Lu-PSMA-617 reduces prostate cancer death risk by 38%

June 4, 2021 Medical Communications

Novartis’s 177Lu-PSMA-617 has shown to significantly improve overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer …
News

BMS announce new positive data from oesophageal cancer study

June 4, 2021 Medical Communications Cancer, oncology

Bristol Myers Squibb (BMS) has announced results from the Phase III CheckMate -648 trial in which nivolumab plus chemotherapy and …
News

Phase III trial shows Olaparib reduces breast cancer recurrence by 42%

June 4, 2021 Medical Communications

Results from OlympiA’s Phase III trial has shown that its Olaparib (Lynparza) in the adjuvant treatment of patients with germline …
News

J&J’s Tremfya sees positive results for post-TNFi psoriatic arthritis

June 4, 2021 Medical Communications J&J, JJ

Johnson & Johnson’s interleukin-23 (IL-23) Tremfya (guselkumab) has shown positive results in Phase IIIb trials, in post-tumour necrosis factor (TNF) …
News

Biosimilars and Brexit: What’s in store for UK’s biosimilar market?

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, brexit

It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …
Feature

The importance of representation in clinical trials

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Representation, clinical trials

Before any kind of new medicine can be made available to the market, it has to go through a strictly …
Feature

Softbox brings in Sean Austerberry as new Director

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Softbox Systems has appointed Sean Austerberry as its Research and Product Development Director. Sean will be responsible for all of …
Appointment
robert_obeirn

Sharp adds Robert O’Beirn to its Global Clinical Services Business

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sharp has appointed Robert O’Beirn as SVP and Managing Director of its global Clinical Services business. In early 2019 Mr …
Appointment
deb_hussain

Debra Hussain new CCO of Acacia Pharma

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Acacia Pharma has appointed Debra Hussain as Chief Commercial Officer. She is a highly experienced commercial leader having spent over …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025